Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.05 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.06 |